SZodixStudyAcademic Library
ShelvesOpen access
Study · an open academic library·Metadata from OpenAlex (CC0)·Shelves·OpenAlex metadata, de-duplicated
Drug shortages in Saudi Arabia: Root causes and recommendations
8 references·2 citing·31 second hop
Drug shortages in Saudi Arabia: Root causes and recommendations (2018)Drug shortages in Saudi Arabia: Root caus…Drug tendering: drug supply and shortage implications for the uptake of biosimilars (2017)Drug tendering: drug supply a…Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study (2016)Current Situation, Determinan…Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy (2016)Addressing the impact of econ…Insights into European Drug Shortages: A Survey of Hospital Pharmacists (2015)Insights into European Drug S…Drug Shortages: A Complex Health Care Crisis (2014)Drug Shortages: A Complex Hea…Drug shortages in European countries: a trade-off between market attractiveness and cost containment? (2014)Drug shortages in European co…Shortages of medicines: a complex global challenge (2012)Shortages of medicines: a com…Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers (2010)Risk sharing arrangements for…Predictors of medicine redistribution at public healthcare facilities in King Cetshwayo District, KwaZulu-Natal, South Africa (2023)Predictors of medicine redist…Localizing pharmaceuticals manufacturing and its impact on drug security in Saudi Arabia (2021)Localizing pharmaceuticals ma…The drug shortage crisis in the United States: causes, impact, and management strategies. (2011)Economic and Technological Drivers of Generic Sterile Injectable Drug Shortages (2012)A Qualitative Approach to a Better Understanding of the Problems Underlying Drug Shortages, as Viewed from Belgian, French and the European Union’s Perspectives (2015)Causes of drug shortages in the legal pharmaceutical framework (2015)Systemic Measures and Legislative and Organizational Frameworks Aimed at Preventing or Mitigating Drug Shortages in 28 European and Western Asian Countries (2018)Using Effectiveness and Cost-effectiveness to Make Drug Coverage Decisions (2009)Health systems in transition. (2010)Cost-Containment Policies in Public Pharmaceutical Spending in the EU (2012)Cancer drugs in 16 European countries, Australia, and New Zealand: a cross-country price comparison study (2015)How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries (2017)Impact of drug shortages on U.S. health systems (2011)Toward a European definition for a drug shortage: a qualitative study (2015)The Iranian health insurance system; past experiences, present challenges and future strategies. (2012)Humanitarian impacts of economic sanctions on Iran and Syria (2014)Iran's health-care system in transition (2016)How health transformation plan was designed and implemented in the Islamic Republic of Iran? (2020)Iran, sanctions, and the COVID-19 crisis (2020)Tracking socio-economic inequalities in healthcare utilization in Iran: a repeated cross-sectional analysis (2020)ASHP Guidelines on Managing Drug Product Shortages in Hospitals and Health Systems (2009)Medicines shortages in Pakistan: a qualitative study to explore current situation, reasons and possible solutions to overcome the barriers (2019)Alleviating Drug Shortages: The Role of Mandated Reporting Induced Operational Transparency (2021)American Society of Clinical Oncology Identifies Five Key Opportunities to Improve Care and Reduce Costs: The Top Five List for Oncology (2012)Key factors in the rising cost of new drug discovery and development (2004)Pharmaceutical supply chain in China: Current issues and implications for health system reform (2010)The Pharmaceutical Industry and the Future of Drug Development (2015)Essential medicines for universal health coverage (2016)ASHP guidelines on managing drug product shortages (2018)Drug Shortage: Causes, Impact, and Mitigation Strategies (2021)Advancing the understanding of pharmaceutical supply chain resilience using complex adaptive system (CAS) theory (2021)Optimization of Inventory Management to Prevent Drug Shortages in the Hospital Supply Chain (2021)Medicine shortages and challenges with the procurement process among public sector hospitals in South Africa; findings and implications (2020)
this work references cited by second hop

References

  • 2014Drug Shortages: A Complex Health Care Crisis288 cited
  • 2010Risk sharing arrangements for pharmaceuticals: potential considerations and recommendations for European payers255 cited
  • 2012Shortages of medicines: a complex global challenge136 cited
  • 2015Insights into European Drug Shortages: A Survey of Hospital Pharmacists132 cited
  • 2014Drug shortages in European countries: a trade-off between market attractiveness and cost containment?128 cited
  • 2016Addressing the impact of economic sanctions on Iranian drug shortages in the joint comprehensive plan of action: promoting access to medicines and health diplomacy101 cited
  • 2016Current Situation, Determinants, and Solutions to Drug Shortages in Shaanxi Province, China: A Qualitative Study70 cited
  • 2017Drug tendering: drug supply and shortage implications for the uptake of biosimilars67 cited

Cited by

  • 2021Localizing pharmaceuticals manufacturing and its impact on drug security in Saudi Arabia53 cited
  • 2023Predictors of medicine redistribution at public healthcare facilities in King Cetshwayo District, KwaZulu-Natal, South Africa11 cited

Only edges whose both ends are imported exist here. Widen the year window, or show the whole map. Back to the work